Stable trading for MetLife stock as Q1 revenue misses analyst expectations

Stable trading for MetLife stock as Q1 revenue misses analyst expectations
MetLife up 0.48% today at $87.98

MetLife Inc. (MET) stock is trading at $87.98, up 0.48% today and closing near the session high. Price action remains above its key moving averages on both the intraday and daily charts, reflecting underlying strength in the short, medium, and long term.

MET price prediction
24H 0.03%
$88.06
48H 0.01%
$88.04
7D 0.18%
$88.19
1M 5.86%
$93.19
3M -0.41%
$87.67
6M 6.59%
$93.83
12M 7.95%
$95.03
Current price: $ 88.03 0.4700 0.54%
Closed 06/23
Daily range 87.18 Arrow from to Icon 88.31
Weekly range 85.40 Arrow from to Icon 87.84
Loading...

Highlights

  • MetLife reported Q1 2026 adjusted earnings per share of $2.42, surpassing consensus estimates and boosting profit outlook.
  • The company launched a new flexible deferred settlement product and maintained management continuity by electing eleven directors and confirming its auditor.
  • Technicals are bullish with strong buying pressure; expected price range is $86.89–$89.07, with high probability of further upside.

Profit outlook lifted as earnings beat offsets revenue miss

MetLife’s earnings outperformance in the first quarter of 2026, with adjusted earnings per share of $2.42 exceeding the $2.25 consensus according to Ca Investing, provides a direct boost to profit outlook and is a key driver for today’s positive sentiment. This earnings surprise outweighs the slight revenue miss for the period and underscores operational efficiency in the current environment. Adding to recent momentum, the company has also launched the Non-Qualified Assignment Flex Agreement, a new flexible deferred settlement product, as reported by Simplywall, while management continuity was assured with the election of eleven directors and ratification of Deloitte & Touche LLP as auditor on June 16, 2026.

Overbought conditions as buyers control above technical supports

On the technical front, MET is trading above its MA-20 at $86.7 and MA-50 at $87.47 on the hourly chart, as well as above the MA-200 at $78.22 on the daily timeframe. The Ichimoku Kijun level at $86.73 provides immediate support. With an intraday RSI reading of 61.36 and a Buy signal from MACD, upside momentum is supported; however, Stoch RSI, CCI, and BBP indicate the stock is overbought, reflecting strong short-term buying pressure. The ADX is neutral, and the Awesome Oscillator aligns with the prevailing uptrend. This setup highlights the dominance of buyers but suggests some caution due to the overbought oscillator readings.

Bullish continuation likely as tight range favors break higher

Looking ahead over the next several days, MET is expected to trade within a typical volatility band between $86.89 and $89.07. The probability of upward continuation remains very high, while a downward break appears unlikely based on current momentum. In the base scenario, prices should stay in this range, but a breakout above resistance could open the door to further gains, while any drop below immediate support may result in a sharper pullback.

Viktoras Karapetjanc, expert at Traders Union, believes MetLife demonstrates solid macro and fundamental momentum. He sees management stability, auditor continuity, and the recent product launch as key positives supporting sentiment. Strong earnings outperformance outweighs the minor revenue miss and keeps the outlook favorable. "With the technical trend strong and fundamentals aligned, I expect MET to stay in its upward channel and see a breakout as likely if current momentum persists."

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.